520 results
Page 3 of 26
425
t9ufop 6z3za1duo5s4e
6 Jul 22
Business combination disclosure
4:05pm
425
2zi fcp96y
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.1
v1dg8zfhbmmp9nwtrr4
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
aqdii1pk
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.1
uyb7careiah
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.2
atqg7rr v1d
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
mkzw0xqqi4gg45xn
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.2
6vz79nc s42gav
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
ube5b6 vx
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.2
bez 5u9l2
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.3
gxtj25z3v6 86unpv7
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
ciz9e31eytqx ze82
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
x58hadt8gq
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
1l9ohfdssb lvt5
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.1
dahq xuqwi4xk3
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm